Anbio Biotechnology (NNNN)
Anbio Biotechnology (NNNN) is a NASDAQ-listed healthcare company in the biotechnology industry. This overview describes the security as common stock and reflects the common equity of Anbio Biotechnology rather than a fund, bond, or other instrument. Based on the provided context, the business is associated with diagnostic testing and related laboratory tools used in clinical and point-of-care settings. Its activities are presented at a broad level, without assuming additional operating details. For investors and market readers, the listing indicates an ordinary equity security tied to the company’s shares on NASDAQ.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NNNN
|
—
|
—
|
—
|
—
|
—
|
—
|
Good
|
—
|
—
|
—
|
0.0%
|
—
|
64.6x
|
13.7x
|
47.9x
|
417.8 M
|
402 M
|
0.0%
|
90.4%
|
374.1
|
—
|
-105.2%
|
